EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC-ND 4.0

The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology

Suzanne van der Gaag, Daniela E Oprea-Lager, André N Vis, Harry Hendrikse, Imke H Bartelink

Cancer Chemotherapy and Pharmacology · 13.07.2026 · 96 (1)

DOI: 10.1007/s00280-026-04925-6 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 13.07.2026. Verfasst von Suzanne van der Gaag und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Antineoplastic Agents, Models, Biological, Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsModels, BiologicalNeoplasmsHumansPrecision MedicineMaximum Tolerated DoseAnimalsProtein Kinase InhibitorsMolecular Targeted TherapyDose-Response Relationship, Drug

Stichwörter der Autor:innen

OncologyPSMAPharmacokineticsPrecision dosingTyrosine-kinase inhibitors

Substanzen

Antineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • , Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, GD, the Netherlands., Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. i.bartelink@amsterdamumc.nl.

Zitieren

APA

van der Gaag, S., Oprea-Lager, D. E., Vis, A. N., Hendrikse, H., & Bartelink, I. H. (2026). The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04925-6

Vancouver

van der Gaag S, Oprea-Lager DE, Vis AN, Hendrikse H, Bartelink IH. The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04925-6

BibTeX
@article{vanderGaag2026,
  author = {van der Gaag, Suzanne and Oprea-Lager, Daniela E and Vis, André N and Hendrikse, Harry and Bartelink, Imke H},
  title = {The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  volume = {96},
  number = {1},
  doi = {10.1007/s00280-026-04925-6}
}
Kostenlos starten →